Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer.
Cell death & disease·2014
Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical cancer treated with radical radiation therapy.
The cancer journal from Scientific American·2000
Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
The cancer journal from Scientific American·2000
Negative margin status improves local control in conservatively managed breast cancer patients.
The cancer journal from Scientific American·2000
The value of postlumpectomy mammogram in the management of breast cancer patients presenting with suspiciouis microcalcifications.
The cancer journal from Scientific American·2000
Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia.
The cancer journal from Scientific American·2000
Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
The cancer journal from Scientific American·2000
Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.
Korean journal of radiology·2026
Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.
Transfusion medicine (Oxford, England)·2026